BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2000
View Archived Issues
Immunosuppressive agents and their use in airways diseases
Read More
SB Biologicals develops vaccine and therapeutic compositions for meningococcal disease
Read More
5-HT receptor ligands in development at Cerebrus for obesity and other disorders
Read More
RP105 antagonists and their use described by SmithKline Beecham
Read More
Synsorb Biotech commences phase III clinical trials with Synsorb Cd for CDAD
Read More
Gemini establishes drug target discovery collaboration with CuraGen
Read More
Canadian government invests heavily in BioChem Pharma's vaccine development program
Read More
Medarex and Coulter form human antibody collaboration agreement
Read More
Sildenafil helps improve conception in an unexpected way
Read More
British Biotech designs more MMP-inhibitory hydroxamic acid derivatives
Read More
Alosetron now available in U.S.; first drug to address multiple symptoms of IBS in women
Read More
Inhibitors of several signal transduction pathways under study at AstraZeneca for cancer, etc.
Read More
Pfizer research team focuses on design of new antitumor agents
Read More
More news from ACS: Oridigm selects two lead apoptosis-inducing polyamine analogues
Read More
NMI-678-11 and NMI-837-11: new nitrosylated moxisylyte derivatives for erectile dysfunction
Read More
Potent second-generation HIV protease inhibitors designed by Vertex & Glaxo Wellcome
Read More
AHP and Elan form alliance to develop Alzheimer's vaccine
Read More
Cardioprotective effects of KB-R9032 involve adenosine receptor stimulation
Read More
Commercial rights to Viadur licensed to Bayer for advanced prostate cancer
Read More
Triangle and Dynavax to develop immunotherapeutics for HIV and hepatitis
Read More
PNU-145185 as lead herpesvirus DNA polymerase inhibitor with broad-spectrum activity
Read More
SafeScience's phase II pancreatic cancer trial commences at Beth Israel Deaconess
Read More
Pyridobenzodiazepine class of antidiuretics with potent oral activity presented at ACS meeting
Read More
Generex initiates clinical trials of oral insulin in Italy
Read More
Novel antitumor agent SJG-136 selected for further preclinical development by NCI
Read More
Onyx and Parke-Davis present cell cycle and biochemical effects of PD-0183812
Read More
Favorable PK, lack of PK interaction with ciclosporin seen for RAD-001 in lung transplant patients
Read More
Merck reports identification of selective, orally active beta3-AR agonist devoid of cardiac effects
Read More